Bae JY - Search Results

1

Downregulation of the RUNX3 gene by promoter hypermethylation and hemizygous deletion in breast cancer.

Hwang KT, Han W, Bae JY, Hwang SE, Shin HJ, Lee JE, Kim SW, Min HJ, Noh DY. Hwang KT, et al. Among authors: bae jy. J Korean Med Sci. 2007 Sep;22 Suppl(Suppl):S24-31. doi: 10.3346/jkms.2007.22.S.S24. J Korean Med Sci. 2007. PMID: 17923751 Free PMC article.

2

Polymorphisms in the estrogen receptor-alpha gene and breast cancer risk.

Kang HJ, Kim SW, Kim HJ, Ahn SJ, Bae JY, Park SK, Kang D, Hirvonen A, Choe KJ, Noh DY. Kang HJ, et al. Among authors: bae jy. Cancer Lett. 2002 Apr 25;178(2):175-80. doi: 10.1016/s0304-3835(01)00861-8. Cancer Lett. 2002. PMID: 11867202

3

Associations between breast cancer susceptibility gene polymorphisms and clinicopathological features.

Han W, Kang D, Park IA, Kim SW, Bae JY, Chung KW, Noh DY. Han W, et al. Among authors: bae jy. Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):124-30. doi: 10.1158/1078-0432.ccr-0834-3. Clin Cancer Res. 2004. PMID: 14734460

4

BetaPix-a enhances the activity of phospholipase Cgamma1 by binding SH3 domain in breast cancer.

Bae JY, Ahn SJ, Lee JE, Kim JE, Han MR, Han W, Kim SW, Shin HJ, Lee SJ, Park D, Noh DY. Bae JY, et al. J Cell Biochem. 2005 Apr 1;94(5):1010-6. doi: 10.1002/jcb.20357. J Cell Biochem. 2005. PMID: 15597340

5

A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.

Han W, Kang D, Lee JE, Park IA, Choi JY, Lee KM, Bae JY, Kim S, Shin ES, Lee JE, Shin HJ, Kim SW, Kim SW, Noh DY. Han W, et al. Among authors: bae jy. Clin Cancer Res. 2005 Jul 1;11(13):4775-8. doi: 10.1158/1078-0432.CCR-04-2208. Clin Cancer Res. 2005. PMID: 16000574

6

Neogenin expression may be inversely correlated to the tumorigenicity of human breast cancer.

Lee JE, Kim HJ, Bae JY, Kim SW, Park JS, Shin HJ, Han W, Kim SW, Kang KS, Noh DY. Lee JE, et al. Among authors: bae jy. BMC Cancer. 2005 Dec 3;5:154. doi: 10.1186/1471-2407-5-154. BMC Cancer. 2005. PMID: 16324219 Free PMC article.

7

Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer.

Han W, Han MR, Kang JJ, Bae JY, Lee JH, Bae YJ, Lee JE, Shin HJ, Hwang KT, Hwang SE, Kim SW, Noh DY. Han W, et al. Among authors: bae jy, bae yj. BMC Cancer. 2006 Apr 12;6:92. doi: 10.1186/1471-2407-6-92. BMC Cancer. 2006. PMID: 16608533 Free PMC article.

8

Peroxiredoxin I and II inhibit H2O2-induced cell death in MCF-7 cell lines.

Bae JY, Ahn SJ, Han W, Noh DY. Bae JY, et al. J Cell Biochem. 2007 Jul 1;101(4):1038-45. doi: 10.1002/jcb.21155. J Cell Biochem. 2007. PMID: 17163455

9

Isolation of CD24(high) and CD24(low/-) cells from MCF-7: CD24 expression is positively related with proliferation, adhesion and invasion in MCF-7.

Kim HJ, Kim JB, Lee KM, Shin I, Han W, Ko E, Bae JY, Noh DY. Kim HJ, et al. Among authors: bae jy. Cancer Lett. 2007 Dec 8;258(1):98-108. doi: 10.1016/j.canlet.2007.08.025. Cancer Lett. 2007. PMID: 17950993

10

Berberine inhibits growth of the breast cancer cell lines MCF-7 and MDA-MB-231.

Kim JB, Lee KM, Ko E, Han W, Lee JE, Shin I, Bae JY, Kim S, Noh DY. Kim JB, et al. Among authors: bae jy. Planta Med. 2008 Jan;74(1):39-42. doi: 10.1055/s-2007-993779. Epub 2008 Jan 17. Planta Med. 2008. PMID: 18203057

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

556 results

Search Page

Filters